Published in Sci Rep on May 12, 2015
What if stem cells turn into embryos in a dish? Nat Methods (2015) 1.12
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Retinoic acid embryopathy. N Engl J Med (1985) 5.85
Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci U S A (2010) 4.63
Development of definitive endoderm from embryonic stem cells in culture. Development (2004) 4.61
Integration of contractile forces during tissue invagination. J Cell Biol (2010) 3.39
Mechanical control of tissue and organ development. Development (2010) 3.18
Emergence of patterned stem cell differentiation within multicellular structures. Stem Cells (2008) 2.34
Tissue deformation modulates twist expression to determine anterior midgut differentiation in Drosophila embryos. Dev Cell (2008) 2.27
Mechanical signals trigger Myosin II redistribution and mesoderm invagination in Drosophila embryos. Sci Signal (2009) 1.89
qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol (2014) 1.77
A method to recapitulate early embryonic spatial patterning in human embryonic stem cells. Nat Methods (2014) 1.70
Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol (2011) 1.69
Teratogen update: valproic acid. Teratology (1987) 1.68
Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J Cell Biochem (2010) 1.53
Analyzing microarray data using cluster analysis. Pharmacogenomics (2003) 1.37
The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat Protoc (2011) 1.21
Building the mouse gastrula: signals, asymmetry and lineages. Curr Opin Genet Dev (2006) 1.19
Thalidomide-induced limb defects: resolving a 50-year-old puzzle. Bioessays (2009) 1.14
Mechanotransduction in development. Curr Top Dev Biol (2011) 1.13
Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol (2010) 1.05
Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells. PLoS One (2012) 1.05
Is nitric oxide decrease observed with naphthoquinones in LPS stimulated RAW 264.7 macrophages a beneficial property? PLoS One (2011) 0.95
Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci (2010) 0.93
Clinical and basic science lessons from the thalidomide tragedy: what have we learned about the causes of limb defects? Teratology (1988) 0.90
Regulation of Stem Cell Fate in a Three-Dimensional Micropatterned Dual-Crosslinked Hydrogel System. Adv Funct Mater (2013) 0.89
A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop. Altern Lab Anim (2009) 0.88
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. Toxicol Appl Pharmacol (2010) 0.87
Patterning pluripotency in embryonic stem cells. Stem Cells (2013) 0.86
Microfluidic-based patterning of embryonic stem cells for in vitro development studies. Lab Chip (2013) 0.85
The development of new concepts for assessing reproductive toxicity applicable to large scale toxicological programmes. Curr Pharm Des (2007) 0.85
Penicillin handling in normal and azotemic patients. J Lab Clin Med (1969) 0.84
Spatially organized in vitro models instruct asymmetric stem cell differentiation. Integr Biol (Camb) (2011) 0.84
Microtubule dynamics analysis using kymographs and variable-rate particle filters. IEEE Trans Image Process (2010) 0.84
Characterisation of a neural teratogenicity assay based on human ESCs differentiation following exposure to valproic acid. Curr Med Chem (2012) 0.83
Assaying embryotoxicity in the test tube: current limitations of the embryonic stem cell test (EST) challenging its applicability domain. Crit Rev Toxicol (2012) 0.80
A high-throughput screen for teratogens using human pluripotent stem cells. Toxicol Sci (2013) 0.80
Modulation of integrin and E-cadherin-mediated adhesions to spatially control heterogeneity in human pluripotent stem cell differentiation. Biomaterials (2015) 0.80
Early embryonic sensitivity to cyclophosphamide in cardiac differentiation from human embryonic stem cells. Cell Biol Int (2011) 0.79
Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening. Birth Defects Res B Dev Reprod Toxicol (2013) 0.79
Teratology Society position paper: recommendations for vitamin A use during pregnancy. Teratology (1987) 0.79
Statement of the scientific validity of the embryonic stem cell test (EST) -- an in Vitro test for embryotoxicity. Altern Lab Anim (2002) 0.78